Table 2.
Medical-Related Factors of Patients on HAART Treatment in Ethiopia, 2020 (n=422)
| Variables | Frequency | Percentage | |
|---|---|---|---|
| Parent HIV/AIDS status | Positive | 126 | 29.9 |
| Negative | 246 | 58.3 | |
| I do not know | 50 | 11.8 | |
| Matrimonial HIV/AIDS status | Positive | 189 | 44.8 |
| Unknown | 89 | 21.1 | |
| Negative | 144 | 34.1 | |
| WHO stage of HIV | Stage I | 240 | 56.9 |
| Stage II | 169 | 40.0 | |
| Stage III | 11 | 2.6 | |
| Stage IV | 2 | 0.5 | |
| CD4 count (cells/dl) | ≤200 | 37 | 8.8 |
| 201–350 | 71 | 16.8 | |
| 351–499 | 127 | 30.1 | |
| ≥500 | 187 | 44.3 | |
| Duration of HAART treatment | 0–2 years | 44 | 10.4 |
| 3–4 years | 50 | 11.8 | |
| 5–10 years | 211 | 50.0 | |
| >10 years | 117 | 27.7 | |
| The severity of HIV/AIDS | No symptom | 366 | 86.7 |
| Had symptom but did not affect the activity of daily living (ADL) | 44 | 10.4 | |
| Had symptom and spent half of the day in bed | 12 | 2.8 | |